Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications

Fig 5

Comparative adverse event-profile of two drugs used for neuropathic pain, epileptic seizures and mood stabilization.

The largest relative differences in the RRRs of either gabapentin or pregabalin are visualized for selected adverse events. The blue arrow indicates adverse events which are stronger associated with gabapentin than pregabalin, the ruby arrow vice versa. Both groups are separated by the dotted line.

Fig 5